A medicament for enhancing an effect of a cancer therapy based on a mode of action of DNA injury, which comprises as an active ingredient a compound represented by the following general formula (I) or a salt thereof:
wherein one of R
1
and R
2
represents hydrogen atom and the other represents the formula —X-A wherein A represents hydrogen atom or an acyl group, X represents oxgen atom or NH; one of R
3
and R
4
represents hydrogen atom and the other represents the following formula:
wherein Y represents a sulfonyl group or a carbonyl group, R
5
represents a cyclic group, Z represents a single bond or a C
1
to C
4
alkylene group, R
6
represents hydrogen atom or a C
1
to C
6
alkyl group.
Design and Synthesis of Arylamidine Derivatives as Serotonin/Norepinephrine Dual Reuptake Inhibitors
作者:Hui Wen、Wen Qin、Guangzhong Yang、Yanshen Guo
DOI:10.3390/molecules24030497
日期:——
To improve the in vivo antidepressantactivity of previously reported serotonin (5-HT) and norepinephrine (NE) dual reuptake inhibitors, three series of arylamidine derivatives were designed and synthesized. The in vitro 5-HT and NE reuptake inhibitory activities of these compounds were evaluated, and compound II-5 was identified as the most potent 5-HT (IC50 = 620 nM) and NE (IC50 = 10 nM) dual reuptake